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VOCAL CORD 
MEDIALIZATION FOR 
UNILATERAL PARALYSIS 
ASSOCIATED WITH 
INTRATHORACIC 
MALIGNANCIES 
Patients with unilateral vocal cord paralysis from intrathoracic malignan- 
cies may have significant dysfunctions of speech, swallowing, ventilation, 
and effective coughing as a result of inadequate compensation of the 
nonparalyzed cord. In patients with already compromised pulmonary 
function, aspiration can be a life-threatening event. Sixty-three patients 
with intrathoracic malignancies required surgical correction of vocal cord 
paralysis. Primary pathology included lung cancer (49), esophageal cancer 
(nine), and miscellaneous tumors (five). Symptoms included hoarseness 
(62), dyspnea (21), aspiration (26), weight loss (19), dysphagia (14), and 
pneumonia (14). The surgical procedures included medial displacement of
the vocal cord with silicone elastomer (48), temporary Gelfoam injection 
(seven), and Teflon (polytetrafluoroethylene) i jection (eight) to move the 
affected cord to a medial position. In 11 patients, the operation was 
performed in the acute postoperative s tting to improve pulmonary toilet. 
Symptomatic improvement was noted in the following proportions of 
affected patients: hoarseness, 92%; dyspnea, 90%; dysphagia, 93%; aspira- 
tion, 92%; pneumonia, 93%; and weight loss, 47%. Overall success rate of 
the intervention was 57 of 63 patients (90%). All 11 patients treated in the 
acute setting had immediate improvement. A variety of complications 
occurred in 17% of patients. Surgical management ofvocal cord paralysis 
in patients with intrathoracic malignancies prevents life-threatening pul- 
monary complications in the acute postoperative s tting. In chronic situa- 
tions, it provides patients with improved speech, swallowing, and pulmo- 
nary function, resulting in improved quality of life, even for patients not 
cured of their disease. (J THORAC CARDIOVASC SURG 1996;111:334-41) 
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surgical treatment of the disease. Carcinomas of the 
lung and esophagus, which account for the majority 
of these tumors, commonly involve intrathoracic 
neurovascular structures. One compromising se- 
quela of this involvement is unilateral vocal cord 
paralysis (UVCP) as a result of direct tumor or 
lymphatic invasion of the vagus or recurrent laryn- 
geal nerve or tumor location, necessitating resection 
or manipulation of the intrathoracic segment of the 
nerve. 
The ability of patients to tolerate UVCP is ex- 
tremely variable. Temporary neuropraxia may last a 
few weeks or as long as 6 to 9 months. Partial palsies 
are often tolerated because of compensation by the 
contralateral vocal cord. Permanent paralysis is tol- 
erated to different degrees, depending on the final 
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resting position of the vocal cord and the ability of 
the contralateral cord to compensate. Compensa- 
tory mechanisms are less able in older patients, 
however, to prevent hoarseness and aspiration from 
becoming detrimental. 1 Even minimal aspiration 
may be debilitating to patients whose pulmonary 
reserve has been diminished by years of smoking, 
chronic obstructive pulmonary disease, and other 
cardiopulmonary comorbidities. Lack of an effective 
cough and loss of modulation of the expiratory 
phase of respiration further increase the risk of 
pulmonary complications. Patients with intratho- 
racic malignancy, who are frequently compromised 
by age and respiratory disease, therefore tend to be 
less tolerant of UVCP. 
Movement of the vocal cords to a medial position 
("medialization") in patients with UVCP is a means 
of improving speech and swallowing function, and of 
diminishing pulmonary dysfunction. Limited data 
exist regarding the impact of this intervention in 
patients with an intrathoracic malignancy. Medial- 
ization can be achieved directly by endolaryngeal 
injection or by external means with transcutaneous 
insertion of a surgically positioned implant. We 
review our experience with these procedures in 63 
consecutive patients with intrathoracic malignancy 
complicated by UVCP. 
Patients and methods 
From July 1, 1991, through December 31, 1994, a total 
of 63 patients with intrathoracic malignancies underwent 
vocal cord medialization for UVCP at Memorial Sloan- 
Kettering Cancer Center. A retrospective chart review 
was performed to document the type and stage of the 
malignancy treated, associated symptoms, treatment, 
cause of UVCP and extent of compensation, i dications 
for and the type of medialization, and outcome of the 
medialization. 
All procedures were performed with a combination of 
topical, local, and intravenous sedative anesthesia. Injec- 
tion of Gelfoam (Upjohn, Kalamazoo, Mich.) or Teflon 
(polytetrafluoroethylene) (Mentor, Norwell, Mass.) was 
performed with the patient in a flexed "sniffing" position. 
An anterior commissure laryngoscope was used to visual- 
ize the larynx. The needle of the injection gun was placed 
deep within the substance ofthe vocalis muscle lateral and 
anterior to the arytenoid. Under direct vision, material 
was injected to cause the medial displacement of the vocal 
cord (Figs. 1 and 2). 
Silicone elastomer medialization, the surgical implanta- 
tion of a handcrafted silicone elastomer implant by the 
modified technique of |sshiki and coworkers, 2 was per- 
formed with the patient in a supine position. A natural 
skin crease over the affected midthyroid laminae was used. 
Flaps were elevated in a subplatysmal p ane. The strap 
muscles were identified in the midline. Strap muscles were 
Fig. 1. Axial section of the larynx with left UVCP on 
phonation with poor compensation. 
elevated free of the affected thyroid lamina. A thyrotomy 
window was created with an otologic bur approximately 7 
mm from the midline. The window typically measured 6 × 
10 mm in a rectangular fashion. The upper border of the 
window was in the midpoint of the superior-inferior 
dimension. An otologic bur was used to remove the 
cartilaginous window. Care was taken to preserve the 
inner perichondrium to allow creation of an inner pocket. 
The implant was designed in a lock-and-key configuration 
(Fig. 3). The length of the implant measured 10 to 12 ram, 
the anterior height was 1.5 to 2.5 mm, and the posterior 
height was 3.5 to 6.0 mm. Additional fixation was not 
required because of the lock-and-key configuration of the 
implant. The wound was closed in multiple layers with 
absorbable sutures. 
The patients were counseled regarding potential fluc- 
tuations in voice during the first 6 weeks, related to edema 
at the operative site. Improvement in dysphagia was 
identified immediately. A foreign-body sensation was 
present for 1 to 2 weeks. Operative timing was defined as 
"acute" when the operation was performed within 2 weeks 
of operative disruption of the recurrent laryngeal nerve, 
"elective" when the procedure was performed 2 weeks to 
6 months after manifestation of paralysis, and "chronic" 
when it was performed 6 months after development of
UVCP. 
Evaluation of preoperative speech, swallowing, and 
pulmonary disability was based on patient and surgeon 
(D. H. K.) assessment. Physical examination focused on 
the separation (in millimeters) of the vocal cords at the 
posterior commissure on phonation. Postoperative assess- 
ment included the patient's and physician's assessment of 
speech, swallowing, and pulmonary function, measure- 
ment of the gap between the vocal cords at the posterior 
commissure, and the use of chest radiographs and re- 
corded weights to determine improvement. Patients in 
whom all symptoms were improved were considered to 
have a successful result. All patients included in this series 
were followed up for a minimum of 3 months. 
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Fig. 2. a, Axial section of Teflon injection with medialization of left true vocal cord. b, 
Coronal section of Teflon injection with placement ofTeflon deep within the substance of the 
thyroarytenoid muscle. 
Results 
There were 51 men and 12 women, with a median 
age of 64 years (range 36 to 87 years). Carcinoma of 
the lung was the most common underlying malig- 
nancy, occurring in 49 patients; carcinoma of the 
esophagus occurred in nine, and other miscella- 
neous tumor types were seen in five. The left vocal 
cord was paralyzed in 51 patients, the right in 12. 
UVCP was caused by the extent of the primary 
tumor in 35 patients and by intentional resection or 
manipulation of the vagus or recurrent laryngeal 
nerve in 28. Symptoms before medialization in- 
cluded; hoarseness (62), aspiration (26), dyspnea 
(21), weight loss (19), dysphagia (16), and pneumo- 
nia (14; Table I). The distance of the gap at the 
posterior one third of the vocal cords was estimated 
to be 1.0 mm in 7 patients, 1.5 mm in 33, 2.0 mm in 
18, 2.5 mm in four, and 3.0 mm in one (Table II). 
Medialization for UVCP was performed in the 
acute postoperative s tting for 11 patients, electively 
for 28 patients, and in the chronic setting for 24 
patients. The primary indications for medialization 
in the acute setting were inability to generate an 
adequate cough (six), aspiration (four), and dys- 
phagia (one). In the elective and chronic settings, 
indications included hoarseness (24), aspiration 
(20), dysphagia (eight), and pneumonia (one). Me- 
dialization was performed on an outpatient basis for 
two patients, as an intercurrent procedure during 
hospital admission in 23 cases, and during a separate 
admission for 38 patients. Seven patients underwent 
temporary medialization with endoscopic injection 
of Gelfoam into the flaccid cord; in one case, this 
procedure was performed twice. Eight patients un- 
derwent permanent medialization with endoscopic 
Teflon injection (Figs. 1 and 2). Forty-eight patients 
underwent permanent surgical implantation of a 
handcrafted silicone elastomer implant by the mod- 
ified technique of Isshiki and associates 2 (Fig. 3); for 
43 this was a primary procedure, for four it was 
performed after endoscopic medialization with Gel- 
foam, and for one it was performed after Teflon 
injection. The median operative time for endoscopic 
injection was 25 minutes; that for silicone elastomer 
medialization was 45 minutes. Blood loss was less 
than 30 ml for all procedures. 
After operation, most patients had no discernable 
separation of the medialized and mobile cords on 
phonation (Table I). There was no residual gap after 
medialization i 35 patients, there was a gap of 0.5 
mm in 23 patients, and there was a gap of 1.0 mm in 
five patients. All patients had a reduction in the gap 
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3a Table I. Vocal cord gap in patients undergoing 
medialization 
GIottic gap (mm) Preoperative Postoperative 
0 0 35 
0.5 0 23 
1.0 7 5 
1.5 33 0 
2.0 18 0 
2.5 4 0 
3,0 1 0 
Table II. Symptomatic improvement in patients 
undergoing medialization 
Symptoms No. of patients No. improved % improved 
Hoarseness 62 57 92 
Aspiration 26 24 92 
Dyspnea 21 19 90 
Weight loss 19 9 47 
Dysphagia 15 14 93 
Pneumonia 14 13 93 
between the posterior one third of the vocal cords 
on phonation. The decrease in the gap size was 0.5 
mm in three patients, 1.0 mm in 19, 1.5 mm in 25, 2.0 
mm in 14, and 2.5 mm in two. 
Vocal cord medialization was successful in 57 of 
63 patients (90%). All patients treated in the acute 
setting had symptomatic improvement (Table II). 
Only 47% of patients with weight loss had a subse- 
quent increase in weight; all of the subsequent 
weight loss was caused by progression of disease, 
however, rather than inability to swallow. Successful 
results were obtained in 88% of the patients treated 
with Teflon injection (7/8) and 94% of those treated 
with silicone elastomer medialization (45/48). There 
was no long-term deterioration i results. 
Follow-up has ranged from 1 to 30 months (me- 
dian 4 months). Currently, 19 patients are alive and 
free of disease (follow-up 3 to 30 months, median 6 
months), 12 are alive with disease (range 3 to 15 
months, median 4 months), and 32 are dead of their 
disease (range 1 to 20 months, median 4 months). 
Among the 31 patients currently alive, only two have 
unsuccessful long-term results, both as a conse- 
quence of complications. 
Length of hospitalization after medialization 
ranged fi'om 0 to 122 days (median 1 day). Of 40 
patients undergoing elective admission for medial- 
ization, two patients were discharged on the day of 
operation, 35 were discharged I day after operation, 
and three were hospitalized longer than 1 day (2, 4, 
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Fig. 3. a, Thyrotomy window with creation of pocket for 
placement of silicone elastomer implant, b, Handcrafted 
silicone elastomer implant, e, Axial section of implant in 
situ with medialization and compensation f the paralyzed 
left true vocal cord. 
and 10 days) because of confounding factors not 
related to medialization. Among 23 patients under- 
going medialization as part of a previous admission, 
one was discharged on the day of medialization, four 
were discharged 1 day after medialization, nine 
patients were hospitalized for between 4 and 9 days, 
eight patients were hospitalized for between 12 and 
18 days, and one patient was hospitalized for 122 
days. Prolonged hospitalization was a consequence 
of the patient's underlying malignancy and not 
related to medialization. 
Complications occurred in 11 patients (17%). 
These were usually minor and included transient 
airway compromise (three), tooth fracture (one), 
hematoma (one), foreign-body sensation (two), and 
transient laryngeal edema (four). Two major com- 
plications occurred in this series. The first was a 
spontaneous extrusion of the implant, associated 
with paroxsmal coughing, 4 months after successful 
medialization. The second complication was airway 
obstruction in a patient undergoing a second Gel- 
foam injection. This patient's first procedure had 
been successful. The patient had significant im- 
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provement in her voice after the second Gelfoam 
injection but remained hospitalized because of per- 
sistent nausea nd vomiting. Sudden airway obstruc- 
tion developed on the first postoperative day, neces- 
sitating emergency tracheostomy, and the patient 
remained hospitalized for 10 days after the trache- 
ostomy. She refused permanent silicone elastomer 
medialization and her voice allows adequate com- 
munication. 
Discussion 
There are limited data on the impact of UVCP in 
patients with intrathoracic malignancies and on the 
impact of surgical rehabilitation. This study was 
performed to determine the effect of surgical medi- 
alization in a selected population. UVCP is a com- 
mon sequela of intrathoracic malignancys. In a 
group of eight pooled series of UVCPs consisting of 
1019 patients, 36% of cases were caused by neo- 
plasms, with more than half of these resulting from 
lung cancer. 3The ability to compensate for UVCP is 
variable. Woo and colleagues 1 associated more se- 
vere vocal dysfunction with older patients, male 
patients, a diagnosis of cancer, and weight loss. 
These authors were unable to correlate any of those 
factors with the presence of aspiration. The inability 
to compensate for aspiration isa result of the degree 
of vocal cord atrophy and loss of pulmonary sup- 
port. In patients with UVCP caused by esophageal 
cancer surgery, Hirano and colleagues 4 found that 
53% aspirated with swallowing and 45% had aspi- 
ration pneumonia. Tracheostomy was necessary in 
25% for the management of persistent aspiration. 
All of our patients had severe hoarseness, which 
impaired communication. We did not perform ob- 
jective preoperative and postoperative oice testing, 
but clinical findings on indirect laryngoscopy are 
known to correlate with decibel output, phonation 
time, and mean flow rate after vocal cord medial- 
ization. 1 Gray and associates 5 compared voice in 
patients undergoing silicone elastomer medializa- 
tion to voice in normal control subjects. Voice was 
comparable with respect o pitch, intonation, and 
loudness, with abnormal values obtained for 
strained, breathy, hoarse, and harsh items. The 
frequency and intensity ranges were decreased for 
the medialization group. In this same population, in 
response to a quality of life questionnaire, 92% 
noted improvement in voice and 93% noted voice 
did not interfere with family interactions, but 25% 
stated that persistent voice change necessitated a - 
justments in employment. In an analysis of long- 
term effect on voice in patients undergoing the 
Isshiki procedure, Leder and Sasaki 6identified high 
fundamental frequency, decreased habitual voice 
intensity, and prolonged maximum phonation time. 
Dysphagia or clinically evident aspiration was 
present in 56% of our patients. There have been no 
reports objectively documenting improvement in 
swallowing after medialization. Netterville and co- 
workers 7have performed primary medializations in
patients undergoing lateral skull-base resection with 
sacrifice of both the superior laryngeal and the 
recurrent laryngeal nerves. Usually, these patients 
require tracheostomy and a gastric feeding tube for 
management of aspiration; this was avoided after 
primary medialization. Koufman s documented im- 
proved swallowing in all patients undergoing medi- 
alization, with mild aspiration in one of 11 patients. 
Aspiration resolved in 13 of 17 patients who under- 
went some form of medialization for UVCP associ- 
ated with esophageal cancer surgery. 4 One patient 
believed to have aspiration in the series reported 
here underwent modified barium swallow examina- 
tion before and after silicone elastomer medializa- 
tion. The patient had undergone an unsuccessful 
Teflon injection at another institution and had a 
gastrostomy for feeding. The postmedialization 
study documents resolution of aspiration, and the 
patient was able to discontinue nteral feedings and 
gain weight eating normally. 
Limited morbidity and no mortality were seen in 
this series. In a series of 60 patients, Tucker and 
associates 9 reported a 10% major complication rate 
consisting of hematoma; all patients required tem- 
porary tracheostomy. In addition, 7% had extrusion 
of the implant. Koufman s reported 18% incidence 
of overall complications in 11 patients undergoing 
silicone elastomer medialization. Thes complica- 
tions included wound infection, implant extrusion, 
pharyngocutaneous fistula, and airway obstruction. 
Gardner, Shaari, and Parnes 1° treated 56 patients 
with UVCP with a variety of Gelfoam, Teflon, and 
silicone elastomer medialization techniques. In that 
series, two patients undergoing Teflon infection had 
airway obstruction ecessitating tracheostomy. The 
reduced morbidity in our series may be the result of 
refinements in silicone elastomer medialization tech- 
nique that have limited local wound complications. 
Life expectancy for these patients with advanced- 
stage disease is often short. In our series, because of 
progressive disease, overall survival has been poor 
(31 of 63 patients are currently alive). There was a 
22% 5-year accrued survival among patients with 
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vocal cord paralysis after esophageal cancer opera- 
tion. 4 Gardner, Shaari, and Parnes 1° noted that 
patients with UVCP caused by lung cancer had the 
worst prognosis of all patients, with only 20% sur- 
vival i year after medialization. The improved qual- 
ity of life and the ability to speak and eat appears to 
justify this intervention, however, even in palliative 
situations. 
The choice of technique should be influenced by 
assessing life expectancy and possible spontaneous 
return of function. Laryngeal electromyography can 
distinguish between permanent injury, in which re- 
innervation is unlikely, and temporary injury, with a 
good prognosis for return of laryngeal function. For 
patients with a potentially intact laryngeal innerva- 
tion, a temporary, reversible procedure such as 
Gelfoam or silicone elastomer medialization should 
be employed. For patients in whom return of laryn- 
geal function is not anticipated, silicone elastomer 
medialization and Teflon injection have been used. 
Teflon has the disadvantages of not being reversible, 
lacking the opportunity for fine adjustments, and 
carrying the potential for long-term formation of 
Teflon granulomas. Endoscopic Teflon injection re- 
quires slightly less time to perform than silicone 
elastomer implantation. Silicone elastomer implanta- 
tion requires an external incision, as well as increased 
operating time; however, there is no local inflamma- 
tory response. H Several authors have reported the 
expeditious performance of silicone elastomer medial- 
ization,2, 5, 7, 9,12 and the average operating time in our 
series was 45 minutes. In patients with deficient supe- 
rior laryngeal nerve innervation, arytenoid adduction 
can be a useful adjunct o or substitute for silicone 
elastomer medialization. 7 This procedure addresses 
the extreme lateralization or "cadaveric" position of 
the paralyzed vocal cord in patients with paralysis of 
both superior and recurrent laryngeal nerves. Because 
all patients reported on in our series have intact 
superior laryngeal innervation, we have not found this 
procedure to be necessary. 
A feature of our experience has been an increas- 
ing reliance on the use of silicone elastomer 
medialization because of consistency of results, dur- 
ability, and technical versatility, including simple 
removal if cord mobility recovers. We believe that 
its use is justified in even short-term palliative 
situations because of its impact on quality of life and 
its lack of morbidity. In acute postoperative situa- 
tions, we operated as early as 2 days after thoracot- 
omy, with a time-limiting factor being the allowance 
for reduction in postintubation laryngeal edema. A 
number of patients (11) have subsequently required 
general anesthesia and intubation after silicone elas- 
tomer medialization as a result of underlying malig- 
nancy, with no reported complications and with 
maintenance of voice and swallowing. 
We thank the attending staff from the Thoracic Radia- 
tion Oncology and Medical Oncology services. We also 
thank Ms. Christine A. Schaar and Ms. Hilary Cathcart for 
their expert assistance in medical illustration and manu- 
script preparation. 
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Discussion 
Dr. F. Gritlith Pearson (Toronto, Ontario, Canada). I do 
not think many really appreciate he potential importance 
for thoracic surgeons of the message you are giving. ! 
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believe this is an important, critical evaluation that you 
have made of the disability that follows UVCP in patients 
that thoracic surgeons operate on for malignant disease, 
particularly lung cancer. It is certainly true that most of 
them are older, and older patients tolerate these compli- 
cations less well. I would like to emphasize that I think the 
major early problem (and you identify 11 patients in 
whom this procedure was done within 2 weeks of opera- 
tion) in these patients is cough failure. Nobody worries 
about hoarseness at this early stage. A few patients 
aspirate, which makes the cough problem worse. Once 
you see a few of these palsies, it is easy to recognize the 
problem the day you first see the patient after operation. 
This patient has a recurrent nerve palsy, cannot hold air, 
and cannot raise secretions, l believe that early interven- 
tion in selected patients may be very useful. 
I note that your data go back to 1991. I have talked with 
Dr. Ginsberg, and I know that this approach was not 
particularly used for acute cases at the Memorial Hospital 
until recently. We have used early augmentation since 
1963, when our otolaryngologic staff first started using 
injectable Teflon. We use glycerin rather than Gelfoam as 
an interim measure, particularly when one does not know 
whether paralysis is permanent or transient. If you have 
not divided the nerve and it was functioning before 
operation and function is lost after operation, you do not 
want to do something permanent to a nerve that may 
recover. You have correctly identified the benefits in late 
reconstruction, with which I think everyone is familiar: 
there, largely, it is restoring the patient's voice. 
The techniques that we have used have been almost 
exclusively oral injection of Teflon under topical anesthe- 
sia. We have had little experience with the transcervical 
approach described. I know, again from talking with 
Dr. Ginsberg, who is familiar with our results in Toronto, 
that he finds your result a little more precise. He is very 
impressed with what you have been able to achieve with 
that approach. 
The complications you have are few. The one trache- 
ostomy, however, is alarming. I do not recall our having to 
do a tracheostomy in any of our patients; certainly in no 
patient managed early on. 
I really wish to emphasize that I think there is an 
important message that may not be widely appreciated by 
thoracic surgeons. This approach is useful, particularly in 
the early postoperative p riod-the first few days, the first 
few weeks. 
I assume, Dr. All, that you are an otolaryngologist. How 
do you recommend we handle the problem of someone 
who, at a month or two after resection where the surgeon 
identified the nerve, thinks it is anatomically intact, but 
there is still a palsy by clinical examination of the larynx? 
You note that electromyography may be helpful. Is it 
absolutely definitive? How do you recommend we pro- 
ceed with such a patient? At what stage, in other words, is 
it reasonable to assume that it is a permanent problem 
and decide to do a permanent-type T flon injection or the 
operation you do with the preformed silicone elastomer? 
Dr. Ali. As you said, laryngeal electromyography actu- 
ally is an excellent method of defining the presence of 
UVCP. I would ask, however, whether the patient still has 
symptoms, because sometimes if the patient's other cord 
has compensated appropriately there are no symptoms. If
there are still symptoms and the electromyogram, which 
basically has an excellent role in distinguishing between 
permanent and temporary paralysis, shows damage, I
think at that point we should go ahead with the procedure. 
Here I should add that we abandoned the Teflon 
injections later during the study because it is a permanent 
procedure. We turned to either Gelfoam or, even better, 
silicone elastomer because although it sounds like a 
surgical procedure it is a temporary procedure that can be 
reversed at any time if the patient's cord function returns. 
We therefore have nothing to lose, even if we err in our 
judgment of the permanence of UVCP, in operating on 
the patient and providing better swallowing and voice. At 
that point, once we have done all the studies and it is 1 to 
2 months after the operation, we should go ahead and 
perform the procedure. It can always be changed back or 
temporized. 
Dr. Pearson. I am still a little confused. How long would 
you wait before judging that it is an irreversible palsy? It 
is a long distance from the aortic arch to the vocal cord, so 
I assume you have to wait 6 months or so. I would like 
your expert opinion about that. 
Dr. Ali. We do not actually have to wait 6 months for 
determination of permanence. We waited with some of 
these patients because that is how they came to us. We can 
do the procedure arlier if our studies show that it is a 
permanent paralysis. 
Dr. Kraus. There are several issues that I would like to 
clarify. Laryngeal electromyography, when it does in fact 
show denervation potentials, is highly specific. In that 
instance, one can anticipate that the cord function will not 
return. We are currently in the process of adding this 
technology to our vocal laboratory. 
We individually determine on which patients we oper- 
ate, and I am unable to provide a uniform approach to 
every patient. The most significant variable depends on 
the degree of dysfunction that the patient exhibits. In a 
hoarse patient who is otherwise free of symptoms, in 
whom my thoracic colleagues have preserved the neural 
innervation to the larynx and we are uncertain whether 
there will be a return in function, I delay surgical inter- 
vention for 3 to 6 months. Other factors that impact on 
this decision are patient issues; early intervention has 
been used in a number of patients for whom voice is 
essential to their profession and it is necessary for them to 
return to their livelihood. As Dr. Ali has correctly pointed 
out, this is a reversible procedure. It is important to note, 
however, that in the 75 patients in whom I have performed 
silicone elastomer medialization, there has been no in- 
stance in which I needed to remove a silicone elastomer 
implant as a consequence of improper assessment of the 
patient. 
Another point that I would like to address is the 
difference between Teflon and silicone elastomer. I con- 
sider myself fortunate to have trained at the Cleveland 
Clinic with Dr. Harvey Tucker while he was one of the 
pioneers who introduced this procedure in this country, 
having adopted it from Isshiki and colleagues, who ini- 
tially developed it in Japan almost 20 to 25 years ago. 
Similarly, i was fortunate to obtain a faculty position in an 
institution that has a highly aggressive group of thoracic 
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surgeons who manage a large number of intrathoracic 
malignancies. 
To me, there is no question at this time that Teflon is 
the least desirable choice. The silicone elastomer proce- 
dure is extremely precise. We are no longer dependent on 
the forces of nature to deposit he Teflon at the desired 
site. We are able to craft the implant in a fashion that 
individualizes it to each person's defect. The procedure is
performed with local anesthesia, and on the basis of 
intraoperative measurements, we are able to carve the 
implant according to each patient's defect. A patient who 
has a large gap or is a large individual will have a larger 
implant han will a smaller-bodied patient or an individual 
with a relatively small gap between the vocal cords. 
The final point that I would like to make is that silicone 
elastomer medialization is an easily taught procedure. I 
now have three or four fellows who completed our 
training program and are performing this technique in 
their practice. It is much easier to teach silicone 
elastomer medialization than the corresponding Teflon 
injection technique. Teflon requires the operating sur- 
geon to determine whether the assistant has properly 
place the needle in the vocal cord and whether the 
correct amount of Teflon has been adjusted. This is all 
performed through the narrow confines of a laryngo- 
scope. The open technique of silicone elastomer allows 
placement of the implant under direct vision, with 
modification of the implant should it be either too small 
or too large. For me, of all the permanent techniques 
this is the procedure of choice. 
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